Joseph Doyle


  • Department of Infectious Diseases, , The Alfred and Central Clinical School, Monash University


  • Level 2, Burnet Institute, 85 Commercial Rd



Accepting PhD Students


Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile


Joseph is a clinician-researcher and dual-trained infectious diseases and public health physician. He has a particular interest in the epidemiology, management and prevention of blood borne viruses (HIV, hepatitis C and hepatitis B).

With a background in clinical medicine, Joseph specialised in infectious diseases at the Alfred where he works as a specialist physician. He completed his MPH at the London School of Hygiene and Tropical Medicine and his public health fellowship was undertaken at the Victorian Infectious Diseases Reference Laboratory and Burnet Institute. His PhD at Monash School of Population Health was focused on the effectiveness of early hepatitis C treatment.

Joseph is currently NHMRC Career Developement Felow and a Senior Research Fellow in Department of Infectious Diseases at The Alfred and Monash University, clinical lead for Alfred Health Population Health Partnership, and jointly appointed as Deputy Director of Disease Elimination Program at Burnet Institute.

Clinical activities

Hepatitis C affects over 230,000 people in Australia. Currently only 1–2% of people with chronic HCV are treated annually. In 2016, the World Health Organization (WHO) has set targets to reduce new HCV infections by 80%, reduce deaths dues to HCV by 65% and eliminate HCV as a public health problem by 2030. With new, effective non-interferon-based treatments it should be possible for Australia to achieve these elimination targets. Key to our success in reducing HCV-related deaths and new infections in Australia will be the upscaling of treatment for all people with chronic HCV infection, including those currently transmitting HCV who are chiefly people you inject drugs. New community-based treatment programs in primary care, drug and alcohol services and community organisations are being rolled out locally. 

Education/Academic qualification

Clinical Medicine, PhD, MONASH UNIVERSITY

Public Health, MPH, London School of Hygiene & Tropical Medicine

Political Science, BA (Hons), University of Melbourne

Medicine, MBBS, University of Melbourne

External positions

Infectious Diseases Specialist, Alfred Health

Deputy Program Director, Disease Elimination, Burnet Institute

Co-Head, Viral Hepatitis Research, Burnet Institute

Research area keywords

  • Viral Hepatitis
  • Public Health
  • Disease Control
  • Disease Prevention
  • Infectious Diseases

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


Research Output

A cost-effectiveness analysis of primary versus hospital-based specialist care for direct acting antiviral hepatitis C treatment

Palmer, A. Y., Wade, A. J., Draper, B., Howell, J., Doyle, J. S., Petrie, D., Thompson, A. J., Wilson, D. P., Hellard, M. E. & Scott, N., Feb 2020, In : International Journal of Drug Policy. 76, 8 p., 102633.

Research output: Contribution to journalArticleResearchpeer-review

Commentary on Barré et al. (2020): Identifying remaining barriers to hepatitis C treatment in the DAA era

Sacks-Davis, R., van Santen, D. K. & Doyle, J. S., 1 Mar 2020, In : Addiction. 115, 3, p. 583-584 2 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

Open Access

Treading lightly: Finding the best way to use public health surveillance of hepatitis C diagnoses to increase access to cure

Stoové, M., Wallace, J., Higgs, P., Pedrana, A., Goutzamanis, S., Latham, N., Scott, N., Treloar, C., Crawford, S., Doyle, J. & Hellard, M., 1 Jan 2020, In : International Journal of Drug Policy. 75, 2 p., 102596.

Research output: Contribution to journalComment / DebateOtherpeer-review

Open Access

Aiming for the elimination of viral hepatitis in Australia, New Zealand, and the Pacific Islands and Territories: Where are we now and barriers to meeting World Health Organization targets by 2030

Howell, J., Pedrana, A., Cowie, B. C., Doyle, J., Getehun, A., Ward, J., Gane, E., Cunningham, C., Wallace, J., Lee, A., Malani, J., Thompson, A. & Hellard, M. E., 1 Jan 2019, In : Journal of Gastroenterology and Hepatology. 34, 1, p. 40-48 9 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

Open Access
2 Citations (Scopus)

Community-based, point-of-care hepatitis C testing: perspectives and preferences of people who inject drugs

Latham, N. H., Pedrana, A., Doyle, J. S., Howell, J., Williams, B., Higgs, P., Thompson, A. J. & Hellard, M. E., Jul 2019, In : Journal of Viral Hepatitis. 26, 7, p. 919-922 4 p.

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)


Priscilla Kincaid-Smith Development Research Grant

Trisha Peel (Recipient) & Joseph Doyle (Recipient), 2016

Prize: Prize (including medals and awards)


  • 1 External research and teaching

Optimising Antimicrobial Use at Epworth Healthcare

Trisha Peel (Fellow), Joseph Doyle (Fellow), Glenn Valoppi (Fellow)

Activity: External Academic EngagementExternal research and teaching